title: [Abdominal dystonia in a patient with schizophrenia: a case report].
abstract: The case of 31-year-old woman suffering from schizophrenia with movement disorder is described. The patient had a 7-year history of schizophrenia. In course of the psychiatric treatment the patient presented dystonic movements within abdominal muscles. The dystonic movements were of mixed character, including voluntary and involuntary ones what might have suggested their psychogenic origin. Subsequent to the exclusion of the neurological origin of the movement disorder and poor response to antipsychotic treatment, clozapine was introduced resulting in full remission of positive symptoms and functional improvement with a diminished intensity of the involuntary movements. Psychogenic movement disorders are uncommon in schizophrenic patients. Movement disorders may occur as an adverse reaction to antipsychotic treatment, especially with typical ones. However, the abdominal muscles dystonia is an uncommon manifestation of dystonia of idiopathic, drug-induced or psychogenic origin. In such cases, a liaison between the neurologist and psychiatrist is advocated and the therapeutic process using antipsychotic treatment is necessary.
authors.affiliation: Kliniki Chorób Psychicznych i Zaburzeń Nerwicowych Katedry Chorób Psychicznych Gdańskiego Uniwersytetu Medycznego.
authors.forename: Hubert M
authors.initials: HM
authors.lastname: Wichowicz
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Jakuszkowiak-Wojten
authors.forename: Jarosław
authors.initials: J
authors.lastname: Sławek
authors.forename: Witold
authors.initials: W
authors.lastname: Sołtan
authors.forename: Wiesław J
authors.initials: WJ
authors.lastname: Cubała
authors.forename: Jerzy
authors.initials: J
authors.lastname: Landowski
mesh_terms: D000005:Abdomen; D000009:Abdominal Muscles; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D004421:Dystonia / Q000139:chemically induced* / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D006801:Humans; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents